A detailed history of Tortoise Investment Management, LLC transactions in Organon & Co. stock. As of the latest transaction made, Tortoise Investment Management, LLC holds 201 shares of OGN stock, worth $3,071. This represents 0.0% of its overall portfolio holdings.

Number of Shares
201
Previous 201 -0.0%
Holding current value
$3,071
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$16.59 - $23.77 $447 - $641
-27 Reduced 11.84%
201 $3,000
Q2 2023

Aug 07, 2023

SELL
$19.27 - $24.63 $154 - $197
-8 Reduced 3.39%
228 $4,000
Q4 2022

Feb 03, 2023

SELL
$23.31 - $28.61 $1,771 - $2,174
-76 Reduced 24.36%
236 $6,000
Q3 2022

Nov 04, 2022

BUY
$23.4 - $34.25 $468 - $685
20 Added 6.85%
312 $7,000
Q1 2022

May 06, 2022

SELL
$30.45 - $39.36 $365 - $472
-12 Reduced 3.95%
292 $10,000
Q2 2021

Jul 30, 2021

BUY
$28.45 - $38.0 $8,648 - $11,552
304 New
304 $9,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Tortoise Investment Management, LLC Portfolio

Follow Tortoise Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tortoise Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tortoise Investment Management, LLC with notifications on news.